Contributors

» obesity, infectious disease and ecology

Most Recent

image: Contributors

Contributors

By | April 1, 2016

Meet some of the people featured in the April 2016 issue of The Scientist.

0 Comments

image: Contributors

Contributors

By | November 1, 2015

Meet some of the people featured in the November 2015 issue of The Scientist.

0 Comments

image: Contributors

Contributors

By | May 1, 2015

Meet some of the people featured in the May 2015 issue of The Scientist.

0 Comments

image: Contributors

Contributors

By | October 1, 2014

Meet some of the people featured in the October 2014 issue of The Scientist.

1 Comment

image: Contributors

Contributors

By and | August 1, 2013

Meet some of the people featured in the August 2013 issue of The Scientist.

0 Comments

image: Contributors

Contributors

By | June 1, 2013

Meet some of the people featured in the June 2013 issue of The Scientist.

0 Comments

image: Contributors

Contributors

By | February 1, 2013

Meet some of the people featured in the February 2013 issue of The Scientist.

0 Comments

image: Contributors

Contributors

By | December 1, 2012

Meet some of the people featured in the December 2012 issue of The Scientist.

0 Comments

Contributors

August 1, 2012

Meet some of the people featured in the August 2012 issue of The Scientist.

0 Comments

Contributors

March 1, 2012

Meet some of the people featured in the March 2012 issue of The Scientist.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham